193 related articles for article (PubMed ID: 20947489)
1. A mouse model for human anal cancer.
Stelzer MK; Pitot HC; Liem A; Schweizer J; Mahoney C; Lambert PF
Cancer Prev Res (Phila); 2010 Dec; 3(12):1534-41. PubMed ID: 20947489
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of Autophagy Contributes to Anal Carcinogenesis.
Carchman EH; Matkowskyj KA; Meske L; Lambert PF
PLoS One; 2016; 11(10):e0164273. PubMed ID: 27706233
[TBL] [Abstract][Full Text] [Related]
3. Dominant role of HPV16 E7 in anal carcinogenesis.
Thomas MK; Pitot HC; Liem A; Lambert PF
Virology; 2011 Dec; 421(2):114-8. PubMed ID: 21999991
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin inhibits anal carcinogenesis in two preclinical animal models.
Stelzer MK; Pitot HC; Liem A; Lee D; Kennedy GD; Lambert PF
Cancer Prev Res (Phila); 2010 Dec; 3(12):1542-51. PubMed ID: 21149330
[TBL] [Abstract][Full Text] [Related]
5. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene.
Herber R; Liem A; Pitot H; Lambert PF
J Virol; 1996 Mar; 70(3):1873-81. PubMed ID: 8627712
[TBL] [Abstract][Full Text] [Related]
6. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
Callejas-Valera JL; Iglesias-Bartolome R; Amornphimoltham P; Palacios-Garcia J; Martin D; Califano JA; Molinolo AA; Gutkind JS
Carcinogenesis; 2016 Oct; 37(10):1014-25. PubMed ID: 27538837
[TBL] [Abstract][Full Text] [Related]
7. HPV16 induces penile intraepithelial neoplasia and squamous cell carcinoma in transgenic mice: first mouse model for HPV-related penile cancer.
Medeiros-Fonseca B; Mestre VF; Estêvão D; Sánchez DF; Cañete-Portillo S; Fernández-Nestosa MJ; Casaca F; Silva S; Brito H; Félix A; Medeiros R; Colaço B; Oliveira PA; Bastos MM; Nelson PS; Vakar-Lopez F; Gaivão I; Brito L; Lopes C; Cubilla AL; Gil da Costa RM
J Pathol; 2020 Aug; 251(4):411-419. PubMed ID: 32488868
[TBL] [Abstract][Full Text] [Related]
8. Activating Mutations in
Shin MK; Payne S; Bilger A; Matkowskyj KA; Carchman E; Meyer DS; Bentires-Alj M; Deming DA; Lambert PF
Clin Cancer Res; 2019 Mar; 25(6):1889-1900. PubMed ID: 30530704
[TBL] [Abstract][Full Text] [Related]
9. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals.
Song S; Pitot HC; Lambert PF
J Virol; 1999 Jul; 73(7):5887-93. PubMed ID: 10364340
[TBL] [Abstract][Full Text] [Related]
10. Pocket proteins suppress head and neck cancer.
Shin MK; Pitot HC; Lambert PF
Cancer Res; 2012 Mar; 72(5):1280-9. PubMed ID: 22237625
[TBL] [Abstract][Full Text] [Related]
11. Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins.
Buonomo T; Carraresi L; Rossini M; Martinelli R
J Transl Med; 2011 Jan; 9():2. PubMed ID: 21205295
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice.
Jabbar S; Strati K; Shin MK; Pitot HC; Lambert PF
Virology; 2010 Nov; 407(1):60-7. PubMed ID: 20797753
[TBL] [Abstract][Full Text] [Related]
13. ErbB-2 receptor cooperates with E6/E7 oncoproteins of HPV type 16 in breast tumorigenesis.
Yasmeen A; Bismar TA; Dekhil H; Ricciardi R; Kassab A; Gambacorti-Passerini C; Al Moustafa AE
Cell Cycle; 2007 Dec; 6(23):2939-43. PubMed ID: 18156804
[TBL] [Abstract][Full Text] [Related]
14. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model.
Strati K; Pitot HC; Lambert PF
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14152-7. PubMed ID: 16959885
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis.
Song S; Liem A; Miller JA; Lambert PF
Virology; 2000 Feb; 267(2):141-50. PubMed ID: 10662610
[TBL] [Abstract][Full Text] [Related]
16. Development of spontaneous hyperplastic skin lesions and chemically induced skin papillomas in transgenic mice expressing human papillomavirus type 16 E6/E7 genes.
Kang JK; Kim JH; Lee SH; Kim DH; Kim HS; Lee JE; Seo JS
Cancer Lett; 2000 Nov; 160(2):177-83. PubMed ID: 11053647
[TBL] [Abstract][Full Text] [Related]
17. Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease.
Gunder LC; Johnson HR; Yao E; Moyer TH; Green HA; Sherer N; Zhang W; Carchman EH
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112993
[TBL] [Abstract][Full Text] [Related]
18. Modeling gene-environment interactions in oral cavity and esophageal cancers demonstrates a role for the p53 R72P polymorphism in modulating susceptibility.
Sarkar J; Dominguez E; Li G; Kusewitt DF; Johnson DG
Mol Carcinog; 2014 Aug; 53(8):648-58. PubMed ID: 23475592
[TBL] [Abstract][Full Text] [Related]
19. A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition.
Jung YS; Kato I; Kim HR
Biochem Biophys Res Commun; 2013 Jun; 435(3):339-44. PubMed ID: 23628416
[TBL] [Abstract][Full Text] [Related]
20. Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential.
Simonson SJ; Difilippantonio MJ; Lambert PF
Cancer Res; 2005 Sep; 65(18):8266-73. PubMed ID: 16166303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
